A
$ Value
$45K
Shares
5,006
Price
$9
Filed
Mar 5
Insider
Name
FOWLER JOHN D JR
Title
—
CIK
0001190344
Roles
Director
Transaction Details
Transaction Date
2026-03-03
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
5,006
Footnotes
Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest in three annual installments beginning on the day prior to the anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.
Filing Info
FOWLER JOHN D JR's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-03 | EBS | A | $45K |
Other Insiders at EBS (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
LINDAHL RICHARD S
EVP, Chief Financial Officer
|
— | — | 2026-03-05 |
|
PAPA JOSEPH C
President and CEO
|
— | — | 2026-03-05 |
|
Glessner Coleen
EVP, Quality & Ethics, and CPL
|
— | — | 2026-03-05 |
|
Williams Paul Anthony
SVP, Products Business
|
— | $34K | 2026-04-01 |
|
Hartzel William
SVP, Bioservices
|
— | — | 2026-03-05 |
|
Perl Jessica
SVP, General Counsel, Corp Sec
|
— | — | 2026-03-05 |
|
Lowry Simon C
SVP, R&D, CMO
|
— | — | 2026-03-05 |